Source: Pharmaphorum

Proteros: AstraZeneca extends oncology partnership with Proteros

AstraZeneca has boosted its research capacity by extending its oncology partnership with Proteros biostructures. German pharma firm ProterosThe post AstraZeneca extends oncology partnership with Proteros appeared first on .

Read full article »

Proteros's Competitors | Proteros's News | Proteros's Financials

Followers on Owler

172

Est. Annual Revenue

$5.0-25M

Est. Employees

100-250

Co-Founder & CEO

Torsten Neuefeind

CEO Approval Rating

85/100

Proteros is a Germany-based CRO that provides services such as drug discovery and biophysical testing for sectors including biotechnology and pharmaceuticals.